-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$57.8031.13% Upside
Q32 Bio Inc. Frequently Asked Questions
-
What analysts cover Q32 Bio Inc.?
Q32 Bio Inc. has been rated by research analysts at Wells Fargo, Leerink Partners, Oppenheimer, Raymond James, Piper Sandler in the past 90 days.